ghk-cu common dosage peptide What is a GHK CU
Description
doi: 10.2337/diabetes.51.1.7
Staying at very low doses long term likely reduces benefit
The peptide influences both endothelial nitric oxide synthase (eNOS), which produces the beneficial, vasodilating form of nitric oxide, and inducible nitric oxide synthase (iNOS), which can produce excessive amounts that contribute to inflammation and tissue damage
It is recommended to start with a low dose of the peptide combination and gradually increase it over time in order to minimize the risk of side effects
Dont freeze insulin keep it cool
